Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1976 Jun;73(6):2123–2127. doi: 10.1073/pnas.73.6.2123

Immunological cross-reactivity of antibodies to a synthetic undecapeptide analogous to the amino terminal segment of carcinoembryonic antigen, with the intact protein and with human sera.

R Arnon, M Bustin, E Calef, S Chaitchik, J Haimovich, N Novik, M Sela
PMCID: PMC430462  PMID: 1064879

Abstract

A peptide corresponding to the 11 amino acid residues of the NH2-terminal portion in the sequence of carcinoembryonic antigen(CNTHETIC CEA(1-11) peptide was attached by means of a water-soluble carbodiimide reagent to multichain poly(DL-alanine( as well as to bovine serum albumin. Both macromolecular conjugates provoked in rabbit anti-CEA(1-11) peptide antibodies. The specificity of this immunological system and the crossreactivity between the peptide and intact CEA were investigated by two methods--passive hemagglutination and modified bacteriophage inactivation. Hemmagglutination experiments showed that not only anti-CEA(1-11) sera, but also anti-CEA sera, agglutinated CEA(1-11)-coated sheep erythrocytes, and both these reactions were inhibited with CEA(1-11) peptide. In experiments with the chemically modified bacteriophage technique CEA(1-11)-coated phase was efficiently inactivated with antisera against the CEA(1-11) conjugates, and the inactivation reaction could be totally inhibited with the free peptide. The semipure CEA, but not the pure protein, could also inhibit the phage inactivation, even though less efficiently. On the basis of the above results, sera of some cancer patients were tested for their capacity to inhibit the inactivation of CEA(1-11)-coated phage by means of anti-CEA(1-11) antiserum. The results indicate that sera from a large proportion of patients with adenocarcinomas of the digestive tract, pancreas, and breast are capable of inhibiting the above inactivation, whereas most normal sera do not inhibit.

Full text

PDF
2123

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERER F. A. VERSUCHE ZUR BESTIMMUNG DER SEROLOGISCH DETERMINANTEN GRUPPEN DES TABAKMOSAIKVIRUS. Z Naturforsch B. 1963 Dec;18:1010–1014. [PubMed] [Google Scholar]
  2. Arnon R., Maron E., Sela M., Anfinsen C. B. Antibodies reactive with native lysozyme elicited by a completely synthetic antigen. Proc Natl Acad Sci U S A. 1971 Jul;68(7):1450–1455. doi: 10.1073/pnas.68.7.1450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arnon R., Sela M. Antibodies to a unique region in lysozyme provoked by a synthetic antigen conjugate. Proc Natl Acad Sci U S A. 1969 Jan;62(1):163–170. doi: 10.1073/pnas.62.1.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BENJAMINI E., YOUNG J. D., SHIMIZU M., LEUNG C. Y. IMMUNOCHEMICAL STUDIES ON THE TOBACCO MOSAIC VIRUS PROTEIN. I. THE IMMUNOLOGICAL RELATIONSHIP OF THE TRYPTIC PEPTIDES OF TOBACCO MOSAIC VIRUS PROTEIN TO THE WHOLE PROTEIN. Biochemistry. 1964 Aug;3:1115–1120. doi: 10.1021/bi00896a018. [DOI] [PubMed] [Google Scholar]
  5. Banjo C., Gold P., Freedman S. O., Krupey J. Immunologically active heterosaccharides of carcinoembryonic antigen of human digestive system. Nat New Biol. 1972 Aug 9;238(84):183–185. doi: 10.1038/newbio238183a0. [DOI] [PubMed] [Google Scholar]
  6. Coligan J. E., Henkart P. A., Todd C. W., Terry W. D. Heterogeneity of the carcinoembryonic antigen. Immunochemistry. 1973 Sep;10(9):591–599. doi: 10.1016/0019-2791(73)90160-2. [DOI] [PubMed] [Google Scholar]
  7. Coligan J. E., Lautenschleger J. T., Egan M. L., Todd C. W. Isolation and characterization of carcinoembryonic antigen. Immunochemistry. 1972 Apr;9(4):377–386. doi: 10.1016/0019-2791(72)90308-4. [DOI] [PubMed] [Google Scholar]
  8. Delwiche R., Zamcheck N., Marcon N. Carcinoembryonic antigen in pancreatitis. Cancer. 1973 Feb;31(2):328–330. doi: 10.1002/1097-0142(197302)31:2<328::aid-cncr2820310209>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  9. Egan M. L., Lautenschleger J. T., Coligan J. E., Todd C. W. Radioimmune assay of carcinoembryonic antigen. Immunochemistry. 1972 Mar;9(3):289–299. doi: 10.1016/0019-2791(72)90093-6. [DOI] [PubMed] [Google Scholar]
  10. GOODFRIEND T. L., LEVINE L., FASMAN G. D. ANTIBODIES TO BRADYKININ AND ANGIOTENSIN: A USE OF CARBODIIMIDES IN IMMUNOLOGY. Science. 1964 Jun 12;144(3624):1344–1346. doi: 10.1126/science.144.3624.1344. [DOI] [PubMed] [Google Scholar]
  11. Gold J. M., Freedman S. O., Gold P. Human anti-CEA antibodies detected by radioimmunoelectrophoresis. Nat New Biol. 1972 Sep 13;239(89):60–62. doi: 10.1038/newbio239060a0. [DOI] [PubMed] [Google Scholar]
  12. Gold P., Freedman S. O. Specific carcinoembryonic antigens of the human digestive system. J Exp Med. 1965 Sep 1;122(3):467–481. doi: 10.1084/jem.122.3.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Haimovich J., Hurwitz E., Novik N., Sela M. Preparation of protein-bacteriophage conjugates and their use in detection of anti-protein antibodies. Biochim Biophys Acta. 1970 Apr 28;207(1):115–124. doi: 10.1016/0005-2795(70)90141-8. [DOI] [PubMed] [Google Scholar]
  14. Haimovich J., Hurwitz E., Novik N., Sela M. Use of protein-bacteriophage conjugates for detection and quantitation of proteins. Biochim Biophys Acta. 1970 Apr 28;207(1):125–129. doi: 10.1016/0005-2795(70)90142-x. [DOI] [PubMed] [Google Scholar]
  15. Krupey J., Gold P., Freedman S. O. Physicochemical studies of the carcinoembryonic antigens of the human digestive system. J Exp Med. 1968 Sep 1;128(3):387–398. doi: 10.1084/jem.128.3.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MERRIFIELD R. B. SOLID-PHASE PEPTIDE SYNTHESIS. 3. AN IMPROVED SYNTHESIS OF BRADYKININ. Biochemistry. 1964 Sep;3:1385–1390. doi: 10.1021/bi00897a032. [DOI] [PubMed] [Google Scholar]
  17. Mach J. P., Pusztaszeri G. Carcinoembryonic antigen (CEA): demonstration of a partial identity between CEA and a normal glycoprotein. Immunochemistry. 1972 Oct;9(10):1031–1034. doi: 10.1016/0019-2791(72)90113-9. [DOI] [PubMed] [Google Scholar]
  18. Maron E., Shiozawa C., Arnon R., Sela M. Chemical and immunological characterization of a unique antigenic region in lysozyme. Biochemistry. 1971 Mar 2;10(5):763–771. doi: 10.1021/bi00781a007. [DOI] [PubMed] [Google Scholar]
  19. Moore T. L., Kantrowitz P. A., Zamcheck N. Carcinoembryonic antigen (CEA) in inflammatory bowel disease. JAMA. 1972 Nov 20;222(8):944–947. [PubMed] [Google Scholar]
  20. Ona F. V., Zamcheck N., Dhar P., Moore T., Kupchik H. Z. Carcinoembryonic antigen (CEA) in the diagnosis of pancreatic cancer. Cancer. 1973 Feb;31(2):324–327. doi: 10.1002/1097-0142(197302)31:2<324::aid-cncr2820310208>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  21. Pusztaszeri G., Mach J. P. Carcinoembryonic antigen (CEA) in non digestive cancerous and normal tissues. Immunochemistry. 1973 Mar;10(3):197–204. doi: 10.1016/0019-2791(73)90008-6. [DOI] [PubMed] [Google Scholar]
  22. Sizaret P., Martin F. Carcinoembryonic antigen in extracts of pulmonary cancers. J Natl Cancer Inst. 1973 Mar;50(3):807–810. doi: 10.1093/jnci/50.3.807. [DOI] [PubMed] [Google Scholar]
  23. Spragg J., Austen K. F., Haber E. Production of antibody against bradykinin: demonstration of specificity by complement fixation and radio-immunoassay. J Immunol. 1966 May;96(5):865–871. [PubMed] [Google Scholar]
  24. Terry W. D., Henkart P. A., Coligan J. E., Todd C. W. Structural studies of the major glycoprotein in preparations with carcinoembryonic antigen activity. J Exp Med. 1972 Jul 1;136(1):200–204. doi: 10.1084/jem.136.1.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Thomson D. M., Krupey J., Freedman S. O., Gold P. The radioimmunoassay of circulating carcinoembryonic antigen of the human digestive system. Proc Natl Acad Sci U S A. 1969 Sep;64(1):161–167. doi: 10.1073/pnas.64.1.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Turner M. D., Olivares T. A., Harwell L., Kleinman M. S. Further purification of perchlorate-soluble antigens from human colonic carcinomata. J Immunol. 1972 May;108(5):1328–1339. [PubMed] [Google Scholar]
  27. von Kleist S., Chavanel G., Burtin P. Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen. Proc Natl Acad Sci U S A. 1972 Sep;69(9):2492–2494. doi: 10.1073/pnas.69.9.2492. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES